Back to results
US 2019/0275091 A1Published application
Anticancer agent comprising hvj-e and immune checkpoint protein inhibitor
AssigneesOsaka University, Genomidea Inc.
InventorsYasufumi KANEDA, Kazuma SAKURA, Tomoyuki NISHIKAWA, Masanori FUKUSHIMA, Toshihiro NAKAJIMA
Life of this patent
Estimating the term…
Abstract
The present invention provides an anticancer agent containing the following (1) and (2): (1) HVJ-E (hemagglutinating virus of Japan envelope), (2) an inhibitor of an immune checkpoint protein.
Claims25
-8. (canceled)
A method for the prophylaxis or treatment of cancer, comprising administering an effective amount of HVJ-E and an inhibitor of an immune checkpoint protein to a subject, thereby preventing or treating cancer in the subject.
Dependencies are inferred from the claim text.